IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q3 FY25 results · Oct–Dec 2024
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹523.30 crore (up 0.6% from Q3 FY24) and net profit of ₹20.53 crore (down 11.0% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 523.30 | 520.39 | +0.6% | 525.75 | −0.5% |
| Other income | 4.07 | 8.38 | −51.4% | 6.43 | −36.7% |
| Total income | 527.37 | 528.77 | −0.3% | 532.18 | −0.9% |
| Profit before tax | 27.80 | 32.09 | −13.4% | 25.94 | +7.2% |
| Net profit for the period | 20.53 | 23.08 | −11.0% | 19.15 | +7.2% |
| EPS, basic (₹) | 3.50 | 3.93 | −10.9% | 3.26 | +7.4% |
| Net margin (%) | 3.9 | 4.4 | 3.6 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 523.30 | 520.39 | +0.6% | 525.75 | −0.5% |
| Other income | 4.07 | 8.38 | −51.4% | 6.43 | −36.7% |
| Total income | 527.37 | 528.77 | −0.3% | 532.18 | −0.9% |
| Profit before tax | 27.82 | 32.24 | −13.7% | 25.94 | +7.2% |
| Net profit for the period | 20.55 | 23.23 | −11.5% | 19.15 | +7.3% |
| EPS, basic (₹) | 3.50 | 3.96 | −11.6% | 3.26 | +7.4% |
| Net margin (%) | 3.9 | 4.5 | 3.6 |
Consolidated
- Filed with BSE
- 12 Feb 2025, 19:25 IST
- Board meeting
- 12 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Feb 2025, 19:25 IST
- Board meeting
- 12 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE